Uncategorised - European Medical Journal

Dupilumab Shows Wider Benefits in Prurigo Nodularis - EMJ

Dupilumab Improves QoL in Patients with Prurigo Nodularis

New trial data show dupilumab improves itch, skin healing and quality of life in patients with prurigo nodularis, even without optimal response.

PrEP Uptake in France Slows HIV Prevention Progress - EMJ

Low PrEP Uptake Slows France’s HIV Prevention Goals

France’s HIV prevention efforts are hindered by low PrEP uptake, especially among women, migrants and younger people despite full health system reimbursement.

Dermatologist discussing medical dermatology updates with a patient during a skin consultation.

SCALE 2026: Dermatology Pearls for Clinical Practice

SCALE 2026 highlighted medical dermatology updates spanning lasers, rosacea, acne, skin aging, and photoprotection.

Physician discussing endometriosis ovarian cancer risk with a patient during a gynecology consultation.

Endometriosis Ovarian Cancer Risk Needs Context

Endometriosis is linked to ovarian cancer risk, but absolute lifetime risk remains low for most patients.

Older adult receiving neurological care after traumatic brain injury and levetiracetam seizure prophylaxis.

Can Seizures Be Prevented After Brain Injury?

Levetiracetam appeared well tolerated after severe traumatic brain injury in octogenarians. Read more.

Pulmonologist reviewing lung imaging for idiopathic pulmonary fibrosis and inhaled treprostinil research.

ATS 2026: TETON-1 Inhaled Treprostinil Slows IPF Decline

Inhaled treprostinil slowed lung function decline in TETON-1, a Phase III trial in idiopathic pulmonary fibrosis.

Venetoclax Regimen Improves Survival in Older Patients with AML

A venetoclax-based AML regimen produced high remission rates and prolonged survival in older or unfit patients with newly diagnosed acute myeloid leukaemia.

Metabolomic Profiling Reveals Hidden Asthma Disease Subtypes

Metabolomic profiling identified distinct biological asthma subgroups despite similar symptom control and exacerbation histories.

Survival Gains in Pancreatic Cancer with Daraxonrasib

Daraxonrasib demonstrated encouraging survival and tumour response outcomes in advanced pancreatic cancer trials.

TNBC Study Identifies Drug Resistant Cell States

Researchers identified persistent drug tolerant cell states in TNBC that survive chemotherapy and may drive metastatic progression and treatment resistance.